1. Home
  2. NSPR vs MGLD Comparison

NSPR vs MGLD Comparison

Compare NSPR & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

BUY

Current Price

$0.46

Market Cap

38.9M

Sector

Health Care

ML Signal

BUY

Logo The Marygold Companies Inc.

MGLD

The Marygold Companies Inc.

BUY

Current Price

$1.98

Market Cap

44.8M

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
NSPR
MGLD
Founded
2005
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
44.8M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
NSPR
MGLD
Price
$0.46
$1.98
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
108.5K
★ 395.8K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.57
EPS
N/A
★ N/A
Revenue
$2,310,000.00
★ $34,876,734.00
Revenue This Year
$9.14
N/A
Revenue Next Year
$105.44
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.46
$0.84
52 Week High
$2.41
$2.12

Technical Indicators

Market Signals
Indicator
NSPR
MGLD
Relative Strength Index (RSI) 24.56 77.91
Support Level N/A $0.91
Resistance Level $1.00 $2.12
Average True Range (ATR) 0.08 0.03
MACD -0.01 -0.01
Stochastic Oscillator 2.19 31.25

Price Performance

Historical Comparison
NSPR
MGLD

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

Share on Social Networks: